2Mesri M,Morales-Ruiz M,Ackermann EJ,et al.Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting[J].Am J Pathol,2003,158(5):1757 ～ 1765.
3Tran J,Rak J,Sheehan C,et al.Marked induction of the IAP family antiapoptotic proteins survivin by VEGF in tumor vascular endothelial cells[J].Biochem Biophys Res Commun,2001,264 (3):781 ～788.
5McManus M T,Sharp P A.Gene silencing in mammals by smallinterfering RNAs[J].Nature Rev Genet,2002,3 (10):737 ～747.
6Aoki Y,Cioca D P,Oidaira H,et al.RNA interference may be morepotent than antisense RNA in human cancer cell lines[J].Clin Exp Pharmacol Physiol,2003,30 (1 ～2):96 ～102.
8Tomas W,Jenkins P G,Howari KA,et al.Particle up2take and translocation across epithelial membranes[J].Anat,1996,(4):4872 ～ 496.
9Siebers A,Finlay B.B.M cell and the pathogenesis of mucosaland systemic infection[J].Trends Microbiol,1996,(4):2372 ～ 2354.
10Rong Xiang,Noriko Mizutani,Yunping Luo,et al.ADNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor[J].Eradication Cancer Research,2005,1565:553 ～ 561.
二级参考文献37
1Steinman RM. The dendritic cell system and its role in immunogenicity[J ]. Am Rev Immmunol, 1991, 9:271.
2Ossevoort MA, Feltkamp KJH, van Veen CJM, et al. Dendritic cells as carriers for a cytotoxic T - lymphocyte epitopebased peptide vaccine n protection against a human papillomavirus type 16 - induced tumor[J ]. Immunother, 1995, 18:86.
3Morse MA, Zhou L J, Tedder TF, et al. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with GM- CSF, IL - 4, and TNFa for use in cancer immunotherapy[J].Ann Surgery, 1997, 226:6.
5Smitak Nair, David Boczkowski, Michael Morse, et al. Iuduction of primary earcinoernbry on ic autigen (CEA) - specific cytotoxic T lymphocytes in vitro using human dentritic cells transfected with RNA[J ]. Research, 1998, 16:364.
6Rains N, Cannan RJ, Chen W, et al. Development of a dendritic cell (DC) - based vaccine for patients with advanced colorectal cancer[J ]. Hepatogastroenterology, 2001, 48(38) : 347.
7Nicole Suciu-Foca, Cortesini, Flavia Piazzab, et al. Distinct mRNA microarray profiles of tolerogenic dendritic cells[J] .Human Immunology, 2001,62(10) : 1065.
8Hadzantonis M, O' NeiU H. Dendritic cell immunotherapy for melanoma [ J ]. Cancer Biother Radiopharm, 1999, 14(1) : 11.
9Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma. Nat Med, 1997, 3(8): 917 -921
10Grossman D, Kim P, Schechner J S, et al. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA,2001, 98 (2): 635 -640
4Swami S , Raghavachari N , Muller UR , et al . Vitamin D growth inhibition of breast cancer cells : gene expression patterns assessed by cDNA microarray[J] . Breast Cancer Res Treat ,2003 , 80( 1 ) : 49 - 62.
5Baum M. The changing face of breast cancer - past , present and futureperspectives [ J ]. Breast Cancer Res Treat,2002,75 ( 1 ) : 1 - 5.
6Kren L, Brazdil J, Hermanova M, et al. Prognostic significance of antiapoptosis proteins survivin and bcl -2 in nonsmall cell lung carcinomas:a elinicopathologic study of 102 cases [ J ]. Appl Immunohistochem Mol- Morphol,2004,12 (1) :44 -49.
7Overhoff M, Alken M, Far RK, et al. Local RNA target structure influences siRNA efficacy : a systematic global analysis [ J ]. J Mol Biol,2005,348(4) :871 -881.
8Tamm I, Macadam Y, Sausville E, el al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas ( CD95 ), Bax,caspases, and anticancer drugs [ J]. Cancer Res, 1998,58 (23) :5315 -5320.
9Lindenbach BD, Rice CM. RNAi targeting an animal virus:news from the front [J]. Mol Cell,2002,9 (5) :925 -927.
10Novina CD, Murray MF, Dykxhoorn DM, et al. siRNA - directed inhibition of HIV - 1 infection [ J]. Nat Med,2002,8 (7) :681 -686.
